Liyun He

机构：Shenyang Pharmaceutical University, Shangrao Normal University, Tongji University, Brigham and Women's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Beijing Anzhen Hospital, Community Health Center, China Agricultural University · ORCID：0000-0002-2450-791X

发表论文 74 篇 · 总被引 1260 次 · h-index 17

代表论文

• Comparative analysis of atherosclerotic cardiovascular disease burden between ages 20–54 and over 55 years: insights from the Global Burden of Disease Study 2019 (2024 · BMC Medicine · 被引 67)
• Sex Differences in the Efficacy of Glucagon‐Like Peptide‐1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta‐Analysis (2025 · Journal of Diabetes · 被引 59)
• Dual-functional gallium/chitosan/silk/umbilical cord mesenchymal stem cell exosome sponge scaffold for diabetic wound by angiogenesis and antibacteria (2024 · International Journal of Biological Macromolecules · 被引 18)
• Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Venous Thromboembolism: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials (2025 · Journal of the American Heart Association · 被引 17)
• Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis (2023 · BMC Public Health · 被引 16)
• Impact of a dual glucose‐dependent insulinotropic peptide/ glucagon‐like peptide ‐1 receptor agonist tirzepatide on heart rate among patients with type 2 diabetes: A systematic review and pairwise and network meta‐analysis (2023 · Diabetes Obesity and Metabolism · 被引 13)